Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
13. Dezember 2024 07:01 ET
|
Genelux Corporation
WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO...
Katapult to Participate in H.C. Wainwright 26th Annual Global Investment Conference
05. September 2024 07:00 ET
|
Katapult Holdings, Inc.
Katapult to participate in investor conference
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
04. September 2024 09:15 ET
|
Cyclacel
Cyclacel to participate at the H.C. Wainwright 26th Annual Global Investment Conference
Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
04. September 2024 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
15. August 2024 12:13 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright
15. Juli 2024 01:30 ET
|
CROSSJECT
Dijon, France, 15 juillet 2024, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), société pharmaceutique de spécialités en phase avancée de développement réglementaire de ZEPIZURE®,...
Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference
15. Juli 2024 01:30 ET
|
CROSSJECT
Dijon, France, July 15th 2024, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company in advanced phases of development and registration for ZEPIZURE®, its emergency...
FibroGen to Participate in Upcoming Investor Conferences
07. Mai 2024 07:00 ET
|
FibroGen, Inc.
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the company’s management will participate in the following investor conferences: Bank of America...
Cingulate Announces Closing of $4.0 Million Public Offering
13. September 2023 16:15 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision...
Cingulate Announces Pricing of $4.0 Million Public Offering
11. September 2023 09:22 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary...